Trade Report: The Adeptus Health Inc. (ADPT) Given a $31.00 Price Target by KeyCorp Analysts

The Adeptus Health Inc. (ADPT) Given a $31.00 Price Target by KeyCorp Analysts

Adeptus Health Inc. (NYSE:ADPT) has been assigned a $31.00 price target by KeyCorp in a research report issued on Wednesday. The brokerage presently has a “buy” rating on the stock. KeyCorp’s target price would indicate a potential upside of 209.69% from the company’s current price.

Several other equities research analysts also recently issued reports on the company. Jefferies Group downgraded Adeptus Health from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $77.00 to $13.00 in a report on Wednesday, November 2nd. JMP Securities lowered their price target on Adeptus Health from $94.00 to $92.00 and set a “market outperform” rating for the company in a report on Wednesday, August 31st. Stephens downgraded Adeptus Health from an “overweight” rating to an “equal weight” rating in a report on Wednesday, November 2nd. Goldman Sachs Group Inc. set a $80.00 price target on Adeptus Health and gave the company a “buy” rating in a report on Thursday, September 8th. Finally, Bank of America Corp. downgraded Adeptus Health from a “buy” rating to an “underperform” rating in a report on Wednesday, November 2nd. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $44.80.

Adeptus Health (NYSE:ADPT) traded up 0.10% during midday trading on Wednesday, reaching $10.01. The company’s stock had a trading volume of 324,080 shares. Adeptus Health has a 1-year low of $7.91 and a 1-year high of $73.44. The company’s 50-day moving average price is $22.87 and its 200-day moving average price is $43.11. The company has a market capitalization of $164.11 million, a price-to-earnings ratio of 1.77 and a beta of 1.22.

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Deerfield Management Co. increased its position in shares of Adeptus Health by 67.4% in the second quarter. Deerfield Management Co. now owns 1,600,861 shares of the company’s stock worth $82,700,000 after buying an additional 644,328 shares during the last quarter. Seven Eight Capital LLC bought a new position in shares of Adeptus Health during the first quarter worth approximately $101,000. Mariner Investment Group LLC increased its position in shares of Adeptus Health by 1.3% in the second quarter. Mariner Investment Group LLC now owns 39,000 shares of the company’s stock worth $2,015,000 after buying an additional 500 shares during the last quarter. First Trust Advisors LP bought a new position in shares of Adeptus Health during the second quarter worth approximately $1,161,000. Finally, Springbok Capital Management LLC bought a new position in shares of Adeptus Health during the first quarter worth approximately $151,000.

Adeptus Health Company Profile

Related posts

Leave a Comment